View in EDS HTML Full Text PDF Full Text

Clinical Trial: Study to Investigate the Efficacy and Safety of the Alpha‐2‐Delta Ligand PD‐217,014 in Patients With Irritable Bowel Syndrome.

Saved in:
Bibliographic Details
Title: Clinical Trial: Study to Investigate the Efficacy and Safety of the Alpha‐2‐Delta Ligand PD‐217,014 in Patients With Irritable Bowel Syndrome.
Authors: Houghton, Lesley A.1,2 (AUTHOR) l.a.houghton@leeds.ac.uk, Gao, Simiao3 (AUTHOR), Gilbert, Steven A.3 (AUTHOR), Coffin, Benoit4 (AUTHOR), Simren, Magnus5 (AUTHOR), Gale, Jeremy D.6 (AUTHOR)
Source: Alimentary Pharmacology & Therapeutics. Mar2025, Vol. 61 Issue 5, p803-813. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:02692813
DOI:10.1111/apt.18487